Anvesana

Biobina, LLC is a New York-based company specializing in the development and distribution of innovative biotechnology products for various industries. With a focus on cutting-edge research and technology, Biobina, LLC strives to provide sustainable solutions that meet the evolving needs of its clients and contribute to advancements in the field of biotechnology. Generated from their business information

SIGA Technologies applies microbial genomics to the design and development of novel products that prevent and treat infectious diseases, as well as defend against biological warfare agents. With technology platforms in both vaccines and antibiotics, the company s platform technologies include a vaccine delivery system that activates the immune system at the body s mucosal surfaces in order to prevent infection at the earliest possible stage, a surface protein expression system for the cost-effective production of proteins, biothreat rapid response therapeutics that can be rapidly designed on demand for any biological pathogen and virus counterstrike capability technology that can be used to develop safe and effective antivirals by targeting the proteinases which are encoded within all viruses. SIGA Technologies is headquartered in New York.

Celdara Medical, LLC is a recognized leader in transforming academic innovations into medicines that cure the world's most challenging diseases. With a rich stable of discoveries developed in collaboration with premiere research institutions, Celdara secures lasting partnerships with inventors and provides the necessary developmental, financial, and business acumen to bridge the gaps between discovery and clinical impact. Driven by integrity, passion, rigor, and a relentless focus on risk mitigation, Celdara constantly strives to create value for all stakeholders. Their commitment to equity, diversity, and inclusion helps drive innovation and save lives, making them a trusted force in the field of medical advancements.Generated from the website